Tuesday, June 21, 2022
HomeExclusiveIs There A Blood Test To Diagnose Dementia

Is There A Blood Test To Diagnose Dementia

How Accurate Is It

Korean researchers develop blood test to diagnose dementia

This quiz is NOT a diagnostic tool. Mental health disorders can only be diagnosed by licensed healthcare professionals.

Psycom believes assessments can be a valuable first step toward getting treatment. All too often people stop short of seeking help out of fear their concerns arent legitimate or severe enough to warrant professional intervention.

If you think you or someone you care about may be suffering from dementia or any other mental health condition, PsyCom.net strongly recommends that you seek help from a mental health professional in order to receive a proper diagnosis and support. For those in crisis, we have compiled a list of resources where you may be able to find additional help at: https://www.psycom.net/get-help-mental-health.

How Does A Doctor Diagnose Dementia

The short answer to how Alzheimers disease is diagnosed in a living patient is through a series of memory and thinking tests that are administered face to face in the doctors office, brain scans, and biomarker tests.

Its important to mention that in a living patient the Alzheimers disease diagnosis is not 100% accurate. Depending on the tests performed, the accuracy can range from 80 to 95 percent in a living person. The only way to be sure that an individual has Alzheimers disease is to look at their brain following death.

Accurate mental status testing to rule out other conditions is key. There are people who have been diagnosed with Alzheimers disease but they have a different medical condition that may mimic it. There are also people who have been diagnosed with other conditions who actually have Alzheimers dementia.

We will cover the whole process from how to assess memory loss to how to get a dementia diagnosis with the highest level of accuracy possible in a living person.

Can Smelling Peanut Butter Detect Alzheimers

The peanut butter test is not how Alzheimers is diagnosed. Most Alzheimers patients do not lose their sense of smell but some do. The loss of sense of smell is called anosmia.

The problem with the peanut butter test is that Parkinsons disease patients can lose their sense of smell too. So, failing the peanut butter test doesnt mean you have Alzheimers disease. COVID or another viral infection could be hurting your sense of smell and could cause you to fail the peanut butter test. And thats temporary.

Its an interesting idea that has roots in some of the symptoms of the disease but its not accurate enough to replace standardized testing.

Also Check: Are Jigsaw Puzzles Good For Dementia

Is Dementia A Mental Illness

Dementia is a mental health disorder as defined by the Diagnostic and Statistical Manual of Mental Disorders. In 2013, the American Psychiatric Association changed the name to Major Neurocognitive Disorder, which is a mouthful. The change was made in order to provide a clearer description of the problem. Whats most important to know is that dementias can involve changes to emotions, behaviors, perceptions, and movements in addition to memory and thinking.

Other Scans And Procedures To Diagnose Dementia

Blood test to detect Alzheimers years before the symptoms ...

Other types of scan, such as a SPECT scan or a PET scan, may be recommended if the result of your MRI or CT scan is uncertain.

However, most people will not need these types of scans.

Both SPECT and PET scans look at how the brain functions, and can pick up abnormalities with the blood flow in the brain.

If a specialist is worried that epilepsy may be causing the dementia symptoms, an EEG may be taken to record the brain’s electrical signals , but this is rare.

Page last reviewed: 3 July 2020 Next review due: 3 July 2023

Recommended Reading: Dementia Awareness Ribbon

What Kind Of Doctor Tests For Dementia

A primary care doctor can perform a physical exam and find out more about your symptoms to determine what may be the cause. They will likely refer you to one or several specialists that can perform specific tests to diagnose dementia. Specialists may include neurologists, who specialize in the brain and nervous system psychiatrists or psychologists, who specialize in mental health, mental functions, and memory or geriatricians, who specialize in healthcare for older adults.

Some Questions You May Wish To Ask You Doctor Regarding Tests Used In Diagnosing Dementia

  • What tests will be conducted?
  • Who will be performing the tests and how long will it take?
  • Should I prepare for the tests in any way?
  • Will any of the tests involve pain or discomfort?
  • Will there be any cost involved?
  • What follow-up will be necessary and who will follow up?
  • How will I be informed of the test results and the diagnosis?

You May Like: Does Meredith Grey Have Alzheimer’s

Blood Tests Show Promise For Early Alzheimers Diagnosis

From NIH Research Matters

With the aging of the U.S. population, the incidence of Alzheimers disease continues to rise. The disease is currently the most common cause of dementia in older adults.

Brain changes associated with Alzheimers include abnormal clumps , tangled bundles of fibers , and the eventual death of nerve cells. These changes can lead to a progressive decline in memory and thinking skills.

Treatments dont yet exist to slow or reverse Alzheimers disease progression. Researchers are working to test new therapies in clinical trials. But no blood tests can currently diagnose Alzheimers before symptoms develop. This complicates studies of early treatments or preventive strategies.

PET imaging and tests that use cerebrospinal fluid can be used to identify Alzheimers before dementia develops. But PET imaging is expensive, and collecting CSF is invasive. Recent research found that measurements of a substance in the blood called ptau181 showed promise as an Alzheimers test.

Scientists have been examining whether another form of the tau protein, called ptau217, can also serve as an early marker of Alzheimers development. Both are found in the tau tangles that accumulate in the brain and can spill into the bloodstream. Two new studies tested different ways of measuring ptau217 in blood samples. The research teams were funded in part by NIHs National Institute on Aging , National Institute of Neurological Disorders and Stroke , and Office of the Director .

Who Should Take The Lbd Test

Researchers find way to assess dementia process using blood tests

This test benefits people who show:

  • Early memory disorder symptoms, which could be Alzheimers or other brain diseases.
  • Signs of cognitive decline and autonomic symptoms, including sleep disorders, constipation, heart rate problems, or fainting spells.
  • Signs of cognitive decline and movement problems, including rigidity, tremors, shuffling or leaning to one side.
  • Read Also: What Color Ribbon Is Alzheimer’s

    Who Is This Dementia Quiz For

    Below is a list of 10 questions designed for people who are concerned about memory loss. The questions relate to life experiences common among people who have been diagnosed with dementia, a neurocognitive disorder, and are based on criteria in the DSM-5 .

    Please read each question carefully, and indicate how often you have experienced the same or similar challenges in the past few months.

    Detecting Alzheimers Gets Easier With A Simple Blood Test

    New assays could reduce the need for costlier, more invasive brain scans and spinal fluid measures

    When a patient complains of forgetfulness, a neurologist might not know immediately whether it results from normal aging, reduced blood flow to the brainor, more ominously, Alzheimers disease. For much of the past century, a definitive Alzheimers diagnosis could only be made during an autopsy. Brain imaging and spinal fluid tests now make it possible to spot the disease in patients even before the initial symptoms appear. But these invasive tests are expensive and generally limited to research settings that are not part of routine care for the millions of people suffering from the most common neurodegenerative disorder.

    An era in which an Alzheimers diagnosis can begin in a doctors office is now arriving. Advances in technologies to detect early signs of disease from a blood sample are helping doctors to identify the memory-robbing disorder more accurately and to screen participants more quickly for trials of potential treatments for the more than five million people in the U.S. afflicted with Alzheimers.

    The development of a blood-based test for Alzheimers disease is just phenomenal, says Michelle Mielke, a neuroscientist and epidemiologist at the Mayo Clinic. The field has been thinking about this for a very long time. Its really been in the last couple of years that the possibility has come to fruition.

    Read Also: Is Senility The Same As Dementia

    Is Alzheimers Diagnosed With A Blood Test

    The other biomarker test, uses either a blood sample or, more commonly, a cerebral spinal fluid sample. The CSF sample is obtained via a spinal tap.

    We look for markers of Alzheimers disease in the blood and the spinal fluid samples. These are pieces of the plaques and tangles that might be circulating in the blood or spinal fluid.

    Therefore, the patient can have a thinking and memory test, and then typically the physician will add on additional tests. One could be a PET scan of the brain and the other one could be a test of either the blood or cerebral spinal fluid.

    Diagnosing Alzheimers disease is a process. And its typically a combination of these three approaches: Cognitive Testing, PET biomarkers and fluid either blood or spinal biomarkers.

    In all cases, personal results are compared to norms. The person is compared to other healthy people in the population that are approximately just like them. Neurologists look at the levels of all of the things that they are measuring to determine if they think its Alzheimers disease.

    And thats how a diagnosis goes.

    Future Of Alzheimers Blood Tests

    RACGP

    When blood tests become mainstream, they will significantly impact the way doctors diagnose and even treat the condition.

    Beyond the Preclivity AD and Simoa described above, there are multiple other types of blood tests in development some are looking at protective fats in the blood. Research shows that an increase in fatty amide levels indicates more beta amyloid in the brain. Beta amyloid plaques have been found in the brains of people with Alzheimers.

    Other blood tests will measure proteins such as tau proteins and the neurofilament light chain protein. Researchers have found that neuron death, characteristic in people with Alzheimers, may be detected by the corresponding increase of these proteins in the blood.

    It is also possible that the probable link between insulin resistance, diabetes and Alzheimers means blood tests could show the disease in someone well before symptoms occur. Another protein called IRS-1 is commonly associated with diabetes but has also been linked to Alzheimers. Studies have shown that someone with Alzheimers has more IRS-1 than even someone with diabetes.

    Recommended Reading: Did Reagan Have Alzheimers

    Alzheimer’s: ‘promising’ Blood Test For Early Stage Of Disease

    A blood test could spot Alzheimer’s disease at the earliest stage and years before symptoms appear, studies in the US and Sweden suggest.

    The test looks for tiny amounts of a protein which is elevated in people with the illness.

    Investigators found measuring this protein, p-tau217, could predict Alzheimer’s dementia with 96% accuracy.

    Experts say that with more research, it could be developed into a test doctors could offer to patients.

    Currently, Alzheimer’s is diagnosed using a combination of memory tests and brain scans, once symptoms have already appeared.

    The idea of a dementia blood test is not new, but these two latest studies give the clearest indication yet that a protein associated with Alzheimer’s disease could be used to diagnose people at a much earlier stage.

    Early diagnosis is important because it could offer more opportunities to treat the disease.

    Dr Rosa Sancho, head of research at Alzheimer’s Research UK, explained that previous clinical trials of drugs had failed because the patients enrolled in them were too far advanced in their illness, and by that time it was “too late”.

    She said: “There’s already too much build-up of damaging proteins in their brain.”

    Alzheimer’s damages the memory and other cognitive abilities by destroying connections between nerve cells in the brain.

    Proteins build up in the brain and cause these cells to die.

    Minimally Invasive Blood Test For Alzheimers Disease Announced

    • News and media
    • Minimally invasive blood test for Alzheimers disease announced

    Scientists from Japan and Australia have teamed up to develop and validate a blood test for Alzheimers disease, with the potential to massively ramp up the pace of Alzheimers disease drug trials.

    The blood test measures a specific peptide in the blood to inform scientists, with 90 per cent accuracy, if a patient has the very earliest stages of Alzheimers disease.

    Blood samples from patients in a large study from the Japanese National Center for Geriatrics and Gerontology were initially analysed to identify the relevant peptides. Those indicating brain beta-amyloid burden were then tested against patient samples from the Australian Imaging, Biomarker and Lifestyle Study of Aging , to validate the results.

    Professor Katsuhiko Yanagisawa, Director-general of Research Institute at NCGG, says: Our study demonstrates the high accuracy, reliability and reproducibility of this blood test, as it was successfully validated in two independent large datasets from Japan and Australia.

    Dr Koichi Tanaka at Shimadzu Corporation was instrumental in developing the initial blood testing procedure. Professor Tanaka won the Nobel prize in Chemistry in 2002 for the technique. From a tiny blood sample, our method can measure several amyloid-related proteins, even though their concentration is extremely low. We found that the ratio of these proteins was an accurate surrogate for brain amyloid burden.

    Don’t Miss: Dementia Color Ribbon

    What Is Dementia Symptoms Types And Diagnosis

    Dementia is the loss of cognitive functioning thinking, remembering, and reasoning to such an extent that it interferes with a person’s daily life and activities. Some people with dementia cannot control their emotions, and their personalities may change. Dementia ranges in severity from the mildest stage, when it is just beginning to affect a person’s functioning, to the most severe stage, when the person must depend completely on others for basic activities of living.

    Dementia is more common as people grow older but it is not a normal part of aging. Many people live into their 90s and beyond without any signs of dementia.

    There are several different forms of dementia, including Alzheimers disease. A persons symptoms can vary depending on the type.

    How Does A Doctor Test For Dementia

    Researchers find way to assess dementia process using blood tests

    There is no single diagnostic test for Alzheimers disease and other causes of dementia. Dementias are diagnosed by evaluating and understanding a persons memory and thinking patterns. Doctors will consider a persons memory, grasp of language, mood states, problem-solving skills, ability to maintain focus and perform complex tasks. Evaluation may include in-office cognitive screening , physical examination, and review of labs. Labwork helps to determine whether there are vitamin deficiencies or hormonal changes at play. In some cases, evaluation may require neuropsychological testing, brain imaging , and genetic testing.

    Recommended Reading: 7th Stage Of Alzheimer’s

    What Are The Benefits Of An Early Alzheimer’s Diagnosis

    Early, accurate diagnosis is beneficial for several reasons. Beginning treatment early in the disease process may help preserve daily functioning for some time, even though the underlying Alzheimers process cannot be stopped or reversed.

    Having an early diagnosis helps people with Alzheimers and their families:

    Scientists Develop Simple Blood Test For Early Detection Of Alzheimer’s Disease

    Date:
    Hong Kong University of Science and Technology
    Summary:
    An international research team has developed a simple but robust blood test from Chinese patient data for early detection and screening of Alzheimer’s disease with an accuracy level of over 96%.

    An international research team led by HKUST has developed a simple but robust blood test from Chinese patient data for early detection and screening of Alzheimer’s disease for the first time, with an accuracy level of over 96%.

    Currently, doctors mainly rely on cognitive tests to diagnose a person with AD. Besides clinical assessment, brain imaging and lumbar puncture are the two most commonly used medical procedures to detect changes in the brain caused by AD. However, these methods are expensive, invasive, and frequently unavailable in many countries.

    “With the advancement of ultrasensitive blood-based protein detection technology, we have developed a simple, noninvasive, and accurate diagnostic solution for AD, which will greatly facilitate population-scale screening and staging of the disease,” said Prof. Nancy Ip, Morningside Professor of Life Science and the Director of the State Key Laboratory of Molecular Neuroscience at HKUST.

    Story Source:

    You May Like: What Color Ribbon Is Alzheimer’s

    Could You Begin With Self

    Yes, you may start with a self-assessment test. Many people who have memory loss concerns might want to start there.

    Even though this is very hard for all humans to do, its best to listen to your friends and family members who might be recognizing things about your memory that you dont.

    If they are expressing concerns about your memory. thats probably a good indication to get it professionally checked by a geriatrician, neurologist or a mental health professional.

    How Long Do Dementia Patients Live After Diagnosis

    Blood test spots early signs of Alzheimers

    Dementia symptoms typically progress slowly. People with dementia will progress from mild to severe dementia at varying speeds and may be diagnosed earlier or later in life. Some people with dementia may live for up to 20 years after their diagnosis, though according to the Alzheimer’s Association research shows that the average person lives for four to eight years after a diagnosis of dementia. It’s important to point out that the diagnosis of dementia is often missed, delayed, or diagnosed when the illness is moderate or advanced. The impact of that variable may not be accurately reflected in the research regarding the years of life post-diagnosis.

    Also Check: How Fast Does Alzheimer’s Progress

    Blood Tests Available Now

    A blood test is available now, through your doctor, that delivers a result in about 10 days and accurately determines whether someone has Alzheimers disease. The Preclivity AD Test from C2N Diagnostics measures proteins in blood plasma that indicate a buildup of plaques known to cause dementia in peoples brains.

    Cost

    The cost of this Alzheimers blood test is $1,250, less expensive than a PET scan that looks for the same protein buildups. Unfortunately, the price tag cannot be covered by Medicare or Medicaid, but C2N says people who cant afford the test can qualify for a discount based on their income.

    Does it Work?

    C2N Diagnostics says they tested Preclivity AD in 686 people and compared it to the results of PET scans. When PET scans showed a high amount of amyloid-beta, a protein that turns to plaques and tangles in the brains of people with Alzheimers, the blood test agreed 92 percent of the time. When the PET scan showed no amyloid, the blood test showed the same about 77 percent of the time.

    How to Get the Blood Test

    The Preclivity AD Test has not been approved by the Food and Drug Administration. It is currently available only through a doctor, and can be sold by the company under rules for commercial laboratories. The test, in other words, is available despite lacking FDA approval, though C2N has said the FDA is planning on reviewing the test in 2021. The Alzheimers Association says it wont endorse the test until there is FDA approval.

    RELATED ARTICLES

    Most Popular